Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Shirong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9334-1637; OpenAlex author ID A5101569068. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2018: 2 papers · 2019: 3 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 7

  1. The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis. Co-author DOI 10.1038/s41388-023-02647-0↗
  2. Activation of the PX1/IL-1β axis in CD41+/CD62P+ platelets enhances pancreatic ductal adenocarcinoma invasion and metastasis Co-author DOI 10.21203/rs.3.rs-307202/v1↗
  3. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery. Co-author DOI 10.1002/cam4.1957↗
  4. Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-018-6941-4↗
  5. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/cmar.s197911↗
  6. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-018-6727-8↗
  7. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Co-author DOI 10.3892/mmr.2018.8763↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaxiang Xu · 6 shared papers, 2018–2023 · strength 0.62
  2. Liang Liu · 4 shared papers, 2019–2023 · strength 0.46
  3. Xianjun Yu · 5 shared papers, 2018–2021 · strength 0.43
  4. Hao Li · 3 shared papers, 2018–2023 · strength 0.37
  5. Wei Jin · 3 shared papers, 2018–2023 · strength 0.33
  6. Quanxing Ni · 4 shared papers, 2018–2019 · strength 0.31
  7. Heli Gao · 4 shared papers, 2018–2019 · strength 0.31
  8. Shuo Li · 4 shared papers, 2018–2019 · strength 0.31
  9. Wenquan Wang · 4 shared papers, 2018–2019 · strength 0.31
  10. Chuntao Wu · 4 shared papers, 2018–2019 · strength 0.31
  11. Tianjiao Li · 3 shared papers, 2019–2021 · strength 0.28
  12. Xian-Jun Yu · 1 shared paper, 2023 · strength 0.18
  13. Wuhu Zhang · 2 shared papers, 2019 · strength 0.16
  14. Liang Liu · 2 shared papers, 2018–2019 · strength 0.15
  15. Long‐Yun Ye · 1 shared paper, 2021 · strength 0.12
  16. Jianfeng Yang · 1 shared paper, 2018 · strength 0.10
  17. Hangbin Jin · 1 shared paper, 2018 · strength 0.10
  18. Shenglin Ma · 1 shared paper, 2018 · strength 0.10
  19. Zi-Hao Qi · 1 shared paper, 2019 · strength 0.08
  20. Wei Jin · 1 shared paper, 2019 · strength 0.08
  21. Lie Yao · 1 shared paper, 2018 · strength 0.07
  22. Deliang Fu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.